Subject to the TSX Venture Exchange (the “Exchange”) consent, the extended expiry date shall be August 5, 2026 (the “Amendment”). All other provisions of the Warrants, such as the Warrants exercise ...
BROSSARD, Quebec, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues ...
TipRanks on MSN
Diagnos Inc. Extends Stock Warrant Exercise Period
Diagnos ( ($TSE:ADK) ) has issued an update. Diagnos Inc. has announced its intention to extend the exercise period of 3,502,931 stock warrants ...
When a company is contemplating a transaction involving an employee stock ownership plan (“ESOP”), there are a lot of considerations regarding structure, including how to retain, incentivize and ...
Opendoor Technologies ($OPEN) has announced a special dividend for its investors. The company will give current shareholders ...
SAN DIEGO, July 09, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of ...
King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage siRNA biopharmaceutical company developing therapeutics using its ...
FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT ...
The new Class I warrants will be exercisable into an aggregate of up to 13,065,000 shares of common stock, will be exercisable beginning on the effective date of stockholder approval of the shares ...
LONDON, UK / ACCESS Newswire / November 14, 2025 / Guardian Metal Resources plc (LON:GMET)(OTCQX:GMTLF), a tungsten exploration and development company, announces that the Company has received a ...
The MarketWatch News Department was not involved in the creation of this content. King of Prussia, Pennsylvania--(Newsfile Corp. - November 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback